BIOMAT Database Logo BIOMAT Database Logo

Phenytoin induced gingival overgrowth in institutionalized epileptics. 1984

T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best

In a cross-sectional, epidemiological study of phenytoin induced gingival overgrowth in 77 institutionalized persons with epilepsy, the severity of the gum lesions was quantified by means of a precise new technique. Lesion severity was then compared statistically to other clinical and laboratory parameters. Positive correlations were detected between overgrowth severity and gingival inflammation, probing depths, calculus accumulation, plaque score and the measurement gingival margin to mucogingival junction (GM-MGJ). No correlation was observed between lesion severity and patients age, daily drug dosage, plasma or saliva phenytoin level, or salivary concentration of the major phenytoin metabolite.

UI MeSH Term Description Entries
D007326 Institutionalization The caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution. Institutionalized Persons,Institutionalizations,Institutionalized Person,Person, Institutionalized,Persons, Institutionalized
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010512 Periodontal Index A numerical rating scale for classifying the periodontal status of a person or population with a single figure which takes into consideration prevalence as well as severity of the condition. It is based upon probe measurement of periodontal pockets and on gingival tissue status. Bleeding on Probing, Gingival,CPITN,Community Periodontal Index of Treatment Needs,Gingival Bleeding on Probing,Gingival Index,Gingival Indexes,Periodontal Indexes,Gingival Indices,Index, Gingival,Index, Periodontal,Indexes, Gingival,Indexes, Periodontal,Indices, Gingival,Indices, Periodontal,Periodontal Indices
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D005885 Gingival Hyperplasia Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400) Gingival Hyperplasias,Hyperplasia, Gingival,Hyperplasias, Gingival
D005891 Gingivitis Inflammation of gum tissue (GINGIVA) without loss of connective tissue. Gingivitides

Related Publications

T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Phenytoin-induced gingival overgrowth.
March 2012, Acta neurologica Scandinavica,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Phenytoin-induced gingival overgrowth.
September 2022, Cleveland Clinic journal of medicine,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Office management of phenytoin-induced gingival overgrowth.
February 1985, The Compendium of continuing education in dentistry,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Phenytoin-induced gingival overgrowth: a case report.
September 1992, Compendium (Newtown, Pa.),
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Proteoglycans and glycosaminoglycans in phenytoin-induced gingival overgrowth.
January 1986, Journal of periodontal research,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Phenytoin-induced severe gingival overgrowth in a child.
July 2014, BMJ case reports,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Phenytoin-induced gingival overgrowth management with periodontal treatment.
January 2015, Brazilian dental journal,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Development of phenytoin-induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs.
April 1987, Acta odontologica Scandinavica,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Phenytoin-induced gingival overgrowth control in severely retarded children.
July 1982, Journal of periodontology,
T Hassell, and J O'Donnell, and J Pearlman, and D Tesini, and T Murphy, and H Best
Phenytoin-induced gingival overgrowth in un-cooperated epilepsy patients.
April 2004, Yonsei medical journal,
Copied contents to your clipboard!